The company said revenue from continuing operations for Q2 (quarter ended July 3, 2026) rose 7.9% to $1,097M, and core revenue grew 6.7%. GAAP net earnings were $157M, GAAP diluted earnings per share were $0.51, and adjusted diluted earnings per share were $0.74.

1. 01

   The company said revenue from continuing operations for Q2 (quarter ended July 3, 2026) rose 7.9% to $1,097M, and core revenue grew 6.7%. GAAP net earnings were $157M, GAAP diluted earnings per share were $0.51, and adjusted diluted earnings per share were $0.74.

2. 02

   Fortive said adjusted EBITDA for Q2 rose 12.0% to $323M, and the adjusted EBITDA margin was 29.5%. Intelligent Operating Solutions revenue was $758M (core 7.4%), and Advanced Healthcare Solutions revenue was $339M (core 5.3%).

3. 03

   The company said GAAP operating cash flow for Q2 was $299M, and free cash flow was $271M. On a trailing 12-month (TTM) basis, operating cash flow was $1,158M, and free cash flow was $1,044M.

4. 04

   The company said it repurchased approximately $200 million of its shares in Q2, and that the cumulative total over the last 4 quarters was approximately $2 billion (approximately 38 million shares). It also said it raised its full-year 2026 adjusted diluted earnings per share guidance to $2.95 to $3.05.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.